Matches in SemOpenAlex for { <https://semopenalex.org/work/W2603085196> ?p ?o ?g. }
- W2603085196 endingPage "2711" @default.
- W2603085196 startingPage "2699" @default.
- W2603085196 abstract "Abstract The tumor suppressor p53 is widely dysregulated in cancer and represents an attractive target for immunotherapy. Because of its intracellular localization, p53 is inaccessible to classical therapeutic monoclonal antibodies, an increasingly successful class of anticancer drugs. However, peptides derived from intracellular antigens are presented on the cell surface in the context of MHC I and can be bound by T-cell receptors (TCR). Here, we report the development of a novel antibody, T1-116C, that acts as a TCR mimic to recognize an HLA-A*0201–presented wild-type p53 T-cell epitope, p5365–73(RMPEAAPPV). The antibody recognizes a wide range of cancers, does not bind normal peripheral blood mononuclear cells, and can activate immune effector functions to kill cancer cells in vitro. In vivo, the antibody targets p5365–73 peptide–expressing breast cancer xenografts, significantly inhibiting tumor growth. This represents a promising new agent for future cancer immunotherapy. Cancer Res; 77(10); 2699–711. ©2017 AACR." @default.
- W2603085196 created "2017-04-07" @default.
- W2603085196 creator A5006655925 @default.
- W2603085196 creator A5008045124 @default.
- W2603085196 creator A5008504672 @default.
- W2603085196 creator A5008969451 @default.
- W2603085196 creator A5013266190 @default.
- W2603085196 creator A5018219367 @default.
- W2603085196 creator A5028427690 @default.
- W2603085196 creator A5039730438 @default.
- W2603085196 creator A5040164104 @default.
- W2603085196 creator A5044956951 @default.
- W2603085196 creator A5051657977 @default.
- W2603085196 creator A5076688601 @default.
- W2603085196 creator A5077510125 @default.
- W2603085196 creator A5083176526 @default.
- W2603085196 creator A5087391847 @default.
- W2603085196 creator A5090536136 @default.
- W2603085196 date "2017-05-14" @default.
- W2603085196 modified "2023-09-30" @default.
- W2603085196 title "Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy" @default.
- W2603085196 cites W1485641535 @default.
- W2603085196 cites W1553725938 @default.
- W2603085196 cites W1901785997 @default.
- W2603085196 cites W1905260826 @default.
- W2603085196 cites W1933510216 @default.
- W2603085196 cites W1963681578 @default.
- W2603085196 cites W1984678830 @default.
- W2603085196 cites W1986388364 @default.
- W2603085196 cites W1986810912 @default.
- W2603085196 cites W1993238204 @default.
- W2603085196 cites W2030522563 @default.
- W2603085196 cites W2033048285 @default.
- W2603085196 cites W2036995752 @default.
- W2603085196 cites W2038181190 @default.
- W2603085196 cites W2039818025 @default.
- W2603085196 cites W2041154353 @default.
- W2603085196 cites W2046771031 @default.
- W2603085196 cites W2047766643 @default.
- W2603085196 cites W2054706573 @default.
- W2603085196 cites W2055985033 @default.
- W2603085196 cites W2065121753 @default.
- W2603085196 cites W2067069532 @default.
- W2603085196 cites W2070854456 @default.
- W2603085196 cites W2076751523 @default.
- W2603085196 cites W2079314872 @default.
- W2603085196 cites W2100100860 @default.
- W2603085196 cites W2100483345 @default.
- W2603085196 cites W2104519476 @default.
- W2603085196 cites W2107884772 @default.
- W2603085196 cites W2116595225 @default.
- W2603085196 cites W2127094135 @default.
- W2603085196 cites W2129141930 @default.
- W2603085196 cites W2134121541 @default.
- W2603085196 cites W2144242764 @default.
- W2603085196 cites W2150057437 @default.
- W2603085196 cites W2157091913 @default.
- W2603085196 cites W2158275874 @default.
- W2603085196 cites W2159414611 @default.
- W2603085196 cites W2160815414 @default.
- W2603085196 cites W2161952857 @default.
- W2603085196 cites W2164835880 @default.
- W2603085196 cites W2190996647 @default.
- W2603085196 doi "https://doi.org/10.1158/0008-5472.can-16-3247" @default.
- W2603085196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28363997" @default.
- W2603085196 hasPublicationYear "2017" @default.
- W2603085196 type Work @default.
- W2603085196 sameAs 2603085196 @default.
- W2603085196 citedByCount "22" @default.
- W2603085196 countsByYear W26030851962017 @default.
- W2603085196 countsByYear W26030851962018 @default.
- W2603085196 countsByYear W26030851962019 @default.
- W2603085196 countsByYear W26030851962020 @default.
- W2603085196 countsByYear W26030851962021 @default.
- W2603085196 countsByYear W26030851962022 @default.
- W2603085196 countsByYear W26030851962023 @default.
- W2603085196 crossrefType "journal-article" @default.
- W2603085196 hasAuthorship W2603085196A5006655925 @default.
- W2603085196 hasAuthorship W2603085196A5008045124 @default.
- W2603085196 hasAuthorship W2603085196A5008504672 @default.
- W2603085196 hasAuthorship W2603085196A5008969451 @default.
- W2603085196 hasAuthorship W2603085196A5013266190 @default.
- W2603085196 hasAuthorship W2603085196A5018219367 @default.
- W2603085196 hasAuthorship W2603085196A5028427690 @default.
- W2603085196 hasAuthorship W2603085196A5039730438 @default.
- W2603085196 hasAuthorship W2603085196A5040164104 @default.
- W2603085196 hasAuthorship W2603085196A5044956951 @default.
- W2603085196 hasAuthorship W2603085196A5051657977 @default.
- W2603085196 hasAuthorship W2603085196A5076688601 @default.
- W2603085196 hasAuthorship W2603085196A5077510125 @default.
- W2603085196 hasAuthorship W2603085196A5083176526 @default.
- W2603085196 hasAuthorship W2603085196A5087391847 @default.
- W2603085196 hasAuthorship W2603085196A5090536136 @default.
- W2603085196 hasBestOaLocation W26030851961 @default.
- W2603085196 hasConcept C121608353 @default.
- W2603085196 hasConcept C147483822 @default.
- W2603085196 hasConcept C151730666 @default.
- W2603085196 hasConcept C154317977 @default.